1. Home
  2. QNCX vs GDO Comparison

QNCX vs GDO Comparison

Compare QNCX & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • GDO
  • Stock Information
  • Founded
  • QNCX 2012
  • GDO 2009
  • Country
  • QNCX United States
  • GDO United States
  • Employees
  • QNCX N/A
  • GDO N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • GDO Finance Companies
  • Sector
  • QNCX Health Care
  • GDO Finance
  • Exchange
  • QNCX Nasdaq
  • GDO Nasdaq
  • Market Cap
  • QNCX 70.4M
  • GDO 84.5M
  • IPO Year
  • QNCX 2019
  • GDO N/A
  • Fundamental
  • Price
  • QNCX $1.59
  • GDO $11.38
  • Analyst Decision
  • QNCX Strong Buy
  • GDO
  • Analyst Count
  • QNCX 4
  • GDO 0
  • Target Price
  • QNCX $9.50
  • GDO N/A
  • AVG Volume (30 Days)
  • QNCX 129.2K
  • GDO 39.4K
  • Earning Date
  • QNCX 11-13-2024
  • GDO 01-01-0001
  • Dividend Yield
  • QNCX N/A
  • GDO 9.81%
  • EPS Growth
  • QNCX N/A
  • GDO N/A
  • EPS
  • QNCX N/A
  • GDO N/A
  • Revenue
  • QNCX N/A
  • GDO N/A
  • Revenue This Year
  • QNCX N/A
  • GDO N/A
  • Revenue Next Year
  • QNCX N/A
  • GDO N/A
  • P/E Ratio
  • QNCX N/A
  • GDO N/A
  • Revenue Growth
  • QNCX N/A
  • GDO N/A
  • 52 Week Low
  • QNCX $0.51
  • GDO $11.21
  • 52 Week High
  • QNCX $2.45
  • GDO $13.04
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 38.88
  • GDO 44.76
  • Support Level
  • QNCX $1.51
  • GDO $11.20
  • Resistance Level
  • QNCX $1.67
  • GDO $11.30
  • Average True Range (ATR)
  • QNCX 0.13
  • GDO 0.08
  • MACD
  • QNCX -0.01
  • GDO 0.02
  • Stochastic Oscillator
  • QNCX 29.49
  • GDO 62.16

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.

Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.

Share on Social Networks: